Tag: Cresco Pharma

Sixth Wave Innovations (SIXW.C) entered into a non-binding letter of intent (LOI) with Halucenex Life Sciences, a soon to be wholly-owned subsidiary of Cresco Pharma. According to the terms outlined in the LOI, Sixth Wave will utilize its Affinity™ in collaboration with Halucenex to explore the separation of compounds such as psilocybin, baeocystin, and others…